Lorberboym M, Wallach F, Estok L, Mosesson R E, Sacher M, Kim C K, Machac J
Department of Radiology, Mount Sinai School of Medicine, City University of New York, New York, USA.
J Nucl Med. 1998 Aug;39(8):1366-9.
The purpose of this study was to determine whether 201Tl retention in focal intracranial lesions can help distinguish central nervous system (CNS) lymphoma from toxoplasmosis and other nonmalignant CNS lesions in patients with acquired immunodeficiency syndrome.
Forty-nine patients who presented with focal lesions on CT and/or MRI had 201Tl brain SPECT studies (early and delayed image sets) performed shortly after admission. Early and delayed 201Tl uptake ratios were obtained for the positive studies, and the retention index of thallium was calculated (delayed/early target-to-background mean count ratio).
Twenty-nine patients had foci of significantly increased 201Tl uptake on the early images in regions of corresponding CT/MRI lesions. Ten of these patients had biopsy-proven lymphomas. Another patient was found to have metastatic adenocarcinoma. Twelve additional patients had a response to radiation therapy or a clinical course consistent with lymphoma and six patients had a false-positive SPECT study. The early uptake ratio could not separate malignant from nonmalignant lesions. The 201Tl retention index in patients with lymphomas (1.18 +/- 0.16) was significantly higher than the retention index in adenocarcinoma (0.24) and in the six nonmalignant lesions (0.62 +/- 0.07). The lowest retention index in patients with lymphoma was 1.07, and the highest retention index in nonmalignant lesions was 0.70. Twenty patients showed no 201Tl uptake in the regions of CT/MRI lesions. Three of them had biopsies consistent with a benign etiology, and one patient was diagnosed with tuberculosis. Fifteen patients improved clinically on antitoxoplasmosis medications alone, and one patient had CNS lymphoma. The overall sensitivity of 201Tl brain SPECT was 96%. The specificity was 76% by counting all studies with abnormal 201Tl uptake, but it increased to 100% when the retention index was also considered.
The retention index increases the specificity of 201Tl brain SPECT in human immunodeficiency virus patients. In the presence of abnormal early 201Tl uptake, it is essential to perform delayed imaging and calculate the retention index to distinguish nonmalignant lesions from lymphoma. The absence of 201Tl uptake on early images at the site of a CT/MRI abnormality excludes the diagnosis of lymphoma with a high degree of confidence and delayed imaging is unnecessary.
本研究的目的是确定局灶性颅内病变中201铊的滞留是否有助于区分获得性免疫缺陷综合征患者的中枢神经系统(CNS)淋巴瘤与弓形虫病及其他非恶性CNS病变。
49例CT和/或MRI显示有局灶性病变的患者在入院后不久进行了201铊脑SPECT研究(早期和延迟图像集)。对阳性研究获得早期和延迟201铊摄取率,并计算铊的滞留指数(延迟/早期靶与本底平均计数比)。
29例患者在相应CT/MRI病变区域的早期图像上有201铊摄取显著增加的病灶。其中10例患者经活检证实为淋巴瘤。另1例患者被发现有转移性腺癌。另有12例患者对放射治疗有反应或临床病程符合淋巴瘤,6例患者SPECT研究为假阳性。早期摄取率无法区分恶性和非恶性病变。淋巴瘤患者的201铊滞留指数(1.18±0.16)显著高于腺癌患者(0.24)和6例非恶性病变患者(0.62±0.07)。淋巴瘤患者的最低滞留指数为1.07,非恶性病变患者的最高滞留指数为0.70。20例患者在CT/MRI病变区域未显示201铊摄取。其中3例活检结果符合良性病因,1例患者被诊断为结核病。15例患者仅接受抗弓形虫病药物治疗后临床症状改善,1例患者患有CNS淋巴瘤。201铊脑SPECT的总体敏感性为96%。通过对所有201铊摄取异常的研究进行计数,特异性为76%,但当同时考虑滞留指数时,特异性提高到100%。
滞留指数提高了201铊脑SPECT在人类免疫缺陷病毒患者中的特异性。在早期201铊摄取异常的情况下,必须进行延迟成像并计算滞留指数,以区分非恶性病变和淋巴瘤。CT/MRI异常部位早期图像上无201铊摄取可高度排除淋巴瘤诊断,无需进行延迟成像。